P3 Health Partners Inc.
PIII
$2.74
-$0.34-11.04%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 2.74% | -2.96% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 11.46% | -2.96% | |||
| Cost of Revenue | 15.22% | 5.25% | |||
| Gross Profit | -68.10% | -652.86% | |||
| SG&A Expenses | 61.74% | -4.50% | |||
| Depreciation & Amortization | -0.18% | -0.24% | |||
| Other Operating Expenses | 333.46% | -297.79% | |||
| Total Operating Expenses | 38.31% | -0.11% | |||
| Operating Income | -247.93% | -29.60% | |||
| Income Before Tax | -140.11% | -66.61% | |||
| Income Tax Expenses | -9,554.55% | -99.44% | |||
| Earnings from Continuing Operations | -138.57% | -59.08% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 138.14% | 62.53% | |||
| Net Income | -139.08% | -55.13% | |||
| EBIT | -247.93% | -29.60% | |||
| EBITDA | -472.97% | -77.82% | |||
| EPS Basic | -138.14% | -55.08% | |||
| Normalized Basic EPS | -150.70% | -101.15% | |||
| EPS Diluted | -376.11% | -55.15% | |||
| Normalized Diluted EPS | -264.95% | -101.15% | |||
| Average Basic Shares Outstanding | 0.40% | 0.03% | |||
| Average Diluted Shares Outstanding | 220.72% | 0.03% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||